More convenient format for media fill broth

Published: 23-Jun-2010
Design & Build Manufacturing Ingredients Packaging Regulatory

Animal-free media fill broth is now available in ready-to-use bags

Provider of microbiology supplies, Oxoid now offers Cold Filterable Vegetable Peptone Broth (cfVPB) in ready-prepared in low-density Bioprocess Containers (BPCs). Designed specifically for pharmaceutical media fill trials, these ready-to-use bags can simply be connected to customers’ process simulation, eliminating the need for bulk media preparation.

The BPCs are manufactured from a medical grade plastic film that meets USP Class VI requirements and are certified free from animal-derived components. Connection is made through a male or female connector that is attached to the BPC with C-Flex tubing.

Oxoid cfVPB is also certified free from animal-derived components, making it ideal for production environments in the pharmaceutical industry, where there is a need to control the risk of contamination from animal-derived materials–particularly with the emergence of diseases such as transmissible spongiform encephalopathies (TSE).

‘BPC’s provide an efficient means for companies to save time and resources,’ said Maria Higgins, pharmaceutical applications manager, Oxoid products. ‘The containers reduce waste and lower cleaning costs. Moreover, the BPCs minimise the risk of cross-contamination, allowing companies to meet regulatory standards.’ says the company.

The cfVPB is gamma-irradiated at a dose validated to be lethal for all yeasts, moulds and bacteria, including bacterial spores and mycoplasmas. The BPCs are, likewise, gamma-irradiated. The medium is prepared using water-for-injection–quality water. The BPCs are aseptically filled, ensuring that the prepared medium is suitable for use in pharmaceutical clean room support areas. The product is also accompanied with quality certification providing full traceability for each batch.

The broth is available as standard in 10 and 20 litre volume BPCs; other sizes are custom-made.
See more

You may also like

Manufacturing

Replacing discontinued OEM degasser modules

Read more
Biotech Fluidics introduces direct replacement OEM degasser modules based on upgraded vacuum technology to support continued fluidic instrument supply without costly redesigns

Trending Articles

  1. FDA approves AstraZeneca's FASENRA for hypereosinophilic syndrome AstraZeneca's FASENRA has received FDA approval for hypereosinophilic syndrome in adults and adolescents aged 12 and above, based on Phase III NATRON trial data showing a 65% reduction in the risk of first HES flare compared to placebo
  2. FDA issues first cGMP warning letter citing AI misuse in pharmaceutical manufacturing A Michigan-based lab has become the subject of the FDA's first dedicated enforcement action on artificial intelligence misuse in drug manufacturing — a landmark event with far-reaching implications for cGMP compliance across the pharmaceutical supply chain
  3. How the QA and QP Talent Market Is Changing in Pharma: Insights from Compliance Unlocked Podcast Recruiting and retaining experienced quality and regulatory professionals has become significantly more complex for pharmaceutical and biotech companies
  4. You need to be a subscriber to read this article.
    Click here to find out more.
    Rice-ing to the occasion: how plant-based excipients are gaining ground in pharmaceutical manufacturing As clean-label expectations migrate from health foods into pharmaceutical supply chains, natural ingredient supplier RIBUS says that rice-based excipients are becoming a credible alternative to synthetic standards

Upcoming event

Cleanroom Technology Conference UK

20-21 May 2026 | Conference and Exhibition | Birmingham, UK See all

You may also like

Manufacturing

Replacing discontinued OEM degasser modules

Biotech Fluidics introduces direct replacement OEM degasser modules based on upgraded vacuum technology to support continued fluidic instrument supply without costly redesigns
Manufacturing

etherna's mRNA and LNP platforms advance Dropshot Therapeutics' renal disease programme to clinical stage

etherna has announced that partner Dropshot Therapeutics has validated its platforms in preclinical renal disease research and will now progress to IND-enabling studies, with etherna providing GMP manufacturing support ahead of planned Phase I clinical trials in 2027
Manufacturing

CARBOGEN AMCIS introduces SPRINT for early-phase development

A new, phase-appropriate approach designed to accelerate early-phase progression while maintaining scientific rigour
Manufacturing

FUJIFILM Cellular Dynamics opens new iPSC manufacturing facility in US

The new site will serve as the company's headquarters and will increase Fujifilm's capacity for induced pluripotent stem cell development and manufacturing, as demand increases with new approach methods in research
You need to be a subscriber to read this article.
Click here to find out more.
Manufacturing

From bespoke to scalable: closing the manufacturing gap in advanced therapeutics

Dr Kevin Robinson (KSR) spoke to Cytiva’s Nicolas Pivet (NP), Vice President of Manufacturing and Digital Solutions, to find out how digitalisation and scalable manufacturing platforms are shaping the next phase of advanced therapeutics
Manufacturing

Piramal Pharma Solutions announces partnership with Botanix to support drug substance development

Piramal Pharma Solutions has entered into an agreement with Botanix SB Inc., a subsidiary of Botanix Pharmaceuticals Limited, to support the development and commercial supply of Sofdra. Sofdra is the first and only FDA-approved new chemical entity (NCE) for the treatment of primary axillary hyperhidrosis. Through this partnership, Piramal Pharma Solutions will leverage the strength of its North American drug substance facilities to support robust, consistent patient access to Sofdra
Manufacturing

ProtaGene and Merck partner to deliver end-to-end biologics testing

The duo will combine ProtaGene's early-stage biologics expertise with Merck's BioReliance GMP testing infrastructure, offering biopharmaceutical customers an integrated testing solution across the full drug development lifecycle
Subscribe now